STAAR Surgical Company (STAA): Price and Financial Metrics

STAAR Surgical Company (STAA): $38.41

0.69 (+1.83%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

B

STAA Price/Volume Stats

Current price $38.41 52-week high $73.13
Prev. close $37.72 52-week low $26.66
Day low $37.51 Volume 445,300
Day high $39.13 Avg. volume 752,243
50-day MA $31.84 Dividend yield N/A
200-day MA $39.98 Market Cap 1.88B

STAA Stock Price Chart Interactive Chart >

STAA POWR Grades

  • Quality is the dimension where STAA ranks best; there it ranks ahead of 77.41% of US stocks.
  • STAA's strongest trending metric is Stability; it's been moving down over the last 26 weeks.
  • STAA ranks lowest in Momentum; there it ranks in the 4th percentile.

STAA Stock Summary

  • STAAR SURGICAL CO's stock had its IPO on March 2, 1992, making it an older stock than 82.13% of US equities in our set.
  • STAA's current price/earnings ratio is 73.31, which is higher than 91.39% of US stocks with positive earnings.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.24 for STAAR SURGICAL CO; that's greater than it is for only 15.07% of US stocks.
  • If you're looking for stocks that are quantitatively similar to STAAR SURGICAL CO, a group of peers worth examining would be TECH, LMAT, MMSI, ETON, and ALGN.
  • Visit STAA's SEC page to see the company's official filings. To visit the company's web site, go to www.staar.com.

STAA Valuation Summary

  • STAA's price/sales ratio is 4.9; this is 16.67% higher than that of the median Healthcare stock.
  • Over the past 243 months, STAA's price/sales ratio has gone up 1.8.

Below are key valuation metrics over time for STAA.

Stock Date P/S P/B P/E EV/EBIT
STAA 2023-12-29 4.9 4.0 78.4 63.4
STAA 2023-12-28 5.1 4.1 80.6 65.3
STAA 2023-12-27 5.0 4.1 79.5 64.4
STAA 2023-12-26 5.0 4.1 80.0 64.7
STAA 2023-12-22 5.0 4.1 79.4 64.3
STAA 2023-12-21 5.1 4.2 80.9 65.5

STAA Growth Metrics

    Its 3 year price growth rate is now at 100.06%.
  • The 4 year revenue growth rate now stands at 82.95%.
  • The 5 year price growth rate now stands at 268.93%.
STAA's revenue has moved up $73,150,000 over the prior 15 months.

The table below shows STAA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 279.348 41.243 37.824
2022-06-30 261.654 39.45 33.582
2022-03-31 242.92 32.586 29.111
2021-12-31 230.472 43.962 24.501
2021-09-30 217.469 55.014 22.906
2021-06-30 206.198 42.287 20.778

STAA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • STAA has a Quality Grade of B, ranking ahead of 92.6% of graded US stocks.
  • STAA's asset turnover comes in at 0.762 -- ranking 41st of 186 Medical Equipment stocks.
  • NVNO, ADMT, and BLFS are the stocks whose asset turnover ratios are most correlated with STAA.

The table below shows STAA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-10-01 0.762 0.772 0.342
2021-07-02 0.784 0.764 0.341
2021-04-02 0.734 0.741 0.208
2021-01-01 0.713 0.724 0.110
2020-10-02 0.722 0.722 0.087
2020-07-03 0.720 0.722 0.056

STAA Price Target

For more insight on analysts targets of STAA, see our STAA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $147.00 Average Broker Recommendation 1.5 (Moderate Buy)

STAAR Surgical Company (STAA) Company Bio


STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver lenses into the eye. The company was founded in 1982 and is based in Monrovia, California.


STAA Latest News Stream


Event/Time News Detail
Loading, please wait...

STAA Latest Social Stream


Loading social stream, please wait...

View Full STAA Social Stream

Latest STAA News From Around the Web

Below are the latest news stories about STAAR SURGICAL CO that investors may wish to consider to help them evaluate STAA as an investment opportunity.

7 Stocks with Strong Insider Buying: December 2023

Stocks with strong insider buying should make you curious, and finding them can be a useful shortcut for your research

Chris Markoch on InvestorPlace | December 17, 2023

Lululemon Athletica gets one more downgrade ahead of Q3 report: 4 big analyst cuts

Unlock the potential of InvestingPro for up to 60% off this Cyber Monday Extended and never miss out on a market winner again.

Yahoo | December 5, 2023

Lilian Zhou Appointed to STAAR Surgical Board of Directors

LAKE FOREST, Calif., December 04, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced the appointment of Lilian Zhou to its Board of Directors, effective December 4, 2023.

Yahoo | December 4, 2023

Should Weakness in STAAR Surgical Company's (NASDAQ:STAA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

With its stock down 18% over the past month, it is easy to disregard STAAR Surgical (NASDAQ:STAA). However, the...

Yahoo | November 16, 2023

STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)

LAKE FOREST, Calif., November 15, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced that management will participate in the Stephens Annual Investment Conference on Thursday, November 16, 2023.

Yahoo | November 15, 2023

Read More 'STAA' Stories Here

STAA Price Returns

1-mo 24.51%
3-mo 23.98%
6-mo -2.49%
1-year -38.12%
3-year -60.27%
5-year -2.51%
YTD 23.07%
2023 -35.70%
2022 -46.83%
2021 15.25%
2020 125.25%
2019 10.22%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!